ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
US Tech 100
21,198.40
1.36%
Dow Jones
43,297.03
0.91%
Brent Oil
73.315
0.04%
Bitcoin
98,158.19
-1.15%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Alnylam Pharmaceuticals Inc (A1LN34) Quote

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (A1LN34)

BOV
73.85
0.35
(0.48%)
Closed December 26 3:55PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
73.85
Bid
10.00
Ask
0.00
Volume
261
73.36 Day's Range 73.85
36.23 52 Week Range 85.44
Market Cap
9.268B
Previous Close
73.50
Open
73.36
Last Trade
1
@
73.85
Last Trade Time
Financial Volume
R$ 19,147
VWAP
73.362
Average Volume (3m)
189
Shares Outstanding
125,493,000
Dividend Yield
-
PE Ratio
-69.34
Earnings Per Share (EPS)
-3.51
Revenue
1.83B
Net Profit
-440.24M

About Alnylam Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.alnylam.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Alnylam Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker A1LN34. The last closing price for Alnylam Pharmaceuticals was R$73.50. Over the last year, Alnylam Pharmaceuticals shares have traded in a share price range of R$ 36.23 to R$ 85.44.

Alnylam Pharmaceuticals currently has 125,493,000 shares outstanding. The market capitalization of Alnylam Pharmaceuticals is R$9.22 billion. Alnylam Pharmaceuticals has a price to earnings ratio (PE ratio) of -69.34.

Ask ADVFN Intelligence (AI)

A1LN34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.56-0.75258701787474.4175.472.118374.25299014DR
40.851.164383561647377.6871.4124274.7658509DR
12-1.33-1.7690875232875.1885.4466.518974.87731042DR
2627.5859.606656580946.2785.4446.2731574.49802624DR
5225.9354.111018363947.9285.4436.2325074.29105282DR
15619.5836.078864934654.2785.4429.8544752.88784555DR
26032.980.341880341940.9585.4429.8549150.54253841DR

A1LN34 - Frequently Asked Questions (FAQ)

What is the current Alnylam Pharmaceuticals share price?
The current share price of Alnylam Pharmaceuticals is R$ 73.85
How many Alnylam Pharmaceuticals shares are in issue?
Alnylam Pharmaceuticals has 125,493,000 shares in issue
What is the market cap of Alnylam Pharmaceuticals?
The market capitalisation of Alnylam Pharmaceuticals is BRL 9.22B
What is the 1 year trading range for Alnylam Pharmaceuticals share price?
Alnylam Pharmaceuticals has traded in the range of R$ 36.23 to R$ 85.44 during the past year
What is the PE ratio of Alnylam Pharmaceuticals?
The price to earnings ratio of Alnylam Pharmaceuticals is -69.34
What is the cash to sales ratio of Alnylam Pharmaceuticals?
The cash to sales ratio of Alnylam Pharmaceuticals is 16.7
What is the reporting currency for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Alnylam Pharmaceuticals?
The latest annual turnover of Alnylam Pharmaceuticals is USD 1.83B
What is the latest annual profit for Alnylam Pharmaceuticals?
The latest annual profit of Alnylam Pharmaceuticals is USD -440.24M
What is the registered address of Alnylam Pharmaceuticals?
The registered address for Alnylam Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Alnylam Pharmaceuticals website address?
The website address for Alnylam Pharmaceuticals is www.alnylam.com
Which industry sector does Alnylam Pharmaceuticals operate in?
Alnylam Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
COCE11Cia Energetica Ceara Coelce
R$ 1.15
(342.31%)
130k
ESTR4Manufatura Brinquedos Estrela Sa
R$ 4.98
(39.89%)
200
AZEV11Azevedo Travassos Sa
R$ 0.24
(20.00%)
30.4k
OSXB3OSX Brasil SA
R$ 3.80
(11.44%)
2.6k
AMBP3Ambipar Participacoes e Empreendimentos SA
R$ 140.00
(10.24%)
214.9k
TKNO3Tekno Sa Ind Com
R$ 40.70
(-45.73%)
9.8k
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
TKNO4Tekno Sa Ind Com
R$ 55.20
(-20.00%)
7.7k
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
CBEE3Ampla Energia Servicos Sa
R$ 10.01
(-16.58%)
600
HAPV3Hapvida Participacoes Investimento SA
R$ 2.25
(-5.46%)
70.23M
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.86
(0.027137%)
43.79M
ABEV3Ambev SA
R$ 12.22
(-0.08%)
40.18M

Discussion

View Full Feed
Seminole Red Seminole Red 11 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/471276104_882978274048002_3316470983360739570_n.jpg?_nc_cat=111&ccb=1-7&_nc_sid=127cfc&_nc_ohc=dT4WqVfoee0Q7kNvgElaTl_&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=A8k3gs7tYPx0EVIlzN-Pcxs&oh=00_AYB4SFr1xl_HIP90B9z9G9_VzgRTy_IzVgSgj6WBXrUyFA&oe=6772C8
flipper44 flipper44 12 minutes ago
I don’t think people read this October 2024 follow up abstract. I’d suggest rereading the abstract until one gets the entire upshot.

https://aacrjournals.org/cancerres/article-abstract/84/19/3130/748704/Hyperactive-Dendritc-Cells-Redirect-Aged-Antitumor?redirectedFrom=fulltext
NWBO
jeunke22 jeunke22 28 minutes ago
Please realize there is a perfect alternative from IBM to POET’s interposers. In the current political climate POET’s ties with China pose a serious business risk. Apparently US institutional investors realize this because their ownership in POET is almost 80% lower than in Lightwave which has 1/3 o
LWLG
Seminole Red Seminole Red 36 minutes ago
Education Department Cancels Loan Cancellation Scheme
Adam Kissel | December 20, 2024

The U.S. Department of Education announced today that it will be withdrawing both parts of its Plan C for student loan cancellation. One part involves various ways the department would have de
stock1ace1 stock1ace1 47 minutes ago
Started a new telegram for stock plays join here -> https://t.me/+YpRHvw-vdyA0MTZh
Zorax Zorax 49 minutes ago
There's no way beer that old would still be good.
But the container would be worth a fortune.

sarcasm- satire.
stock1ace1 stock1ace1 50 minutes ago
SNPX $3.04 ($19.6 Million cash on balance sheet with 1.3 million float)
$19,600,000 / 1,300,000 float = $15 cash per share !

They also formed an independent Special Committee to explore strategic opportunities to create and enhance value for investors on Dec 20, 2024
stock1ace1 stock1ace1 50 minutes ago
SNPX $3.04 ($19.6 Million cash on balance sheet with 1.3 million float)
$19,600,000 / 1,300,000 float = $15 cash per share

They also formed an independent Special Committee to explore strategic opportunities to create and enhance value for investors on Dec 20, 2024
ReasearchThis ReasearchThis 56 minutes ago
CDers will eventually run AXXA to over a dollar.
.
I am sure some of you remember when brokerage companies changed $5 more or less. To make a trade. So how did it get to the point, That buying or selling 200 shares of axxa/any stock for $.0008 cents makes any sense at all.? That is w
AXXA
green maschine green maschine 59 minutes ago
Certain Warrants of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending TODAY. Tnxp currently @ .4031
https://www.marketscreener.com/quote/stock/TONIX-PHARMACEUTICALS-HOL-154457268/news/Certain-Warrants-of-Tonix-Pharmaceuticals-Holding-Corp-are-subject-to-a-Lock-Up-A
TNXP
nowwhat2 nowwhat2 1 hour ago
117,000 has been on my radar as well.......That's where I've estimated THIS to be ;

But yer sayin' ?
No way we slug up to only just that ?


https://investorshub.advfn.com/uimage/uploads/2024/12/25/lsnvxBTC_121212_15_HYPER_EOY_TARGET_117.jpg
BTCUSD
mrfence mrfence 1 hour ago
Say Marie, are the poor allowed to rent, and eat cake too?
Good, let the poor rent.
FNMA
Homebrew Homebrew 1 hour ago
Of course a few get shorted...duh. Few and far between. But yelling "shorts" on every worthless Stinky-Pinky is laughable.
SAPX
nowwhat2 nowwhat2 1 hour ago
Channel Of Destiny / 100k

https://investorshub.advfn.com/uimage/uploads/2024/12/26/evyvgxrp_121212_25_15d_7am_CHAN_OF_DESTINY.jpg


14 HOURS LATER

https://investorshub.advfn.com/uimage/uploads/2024/12/26/mggdjxrp_121212_25_15d_930PM_CHAN_OF_DESTINY.
XRPUSD
wadegarret wadegarret 1 hour ago
Hope high flying tech fades & value shines

in 2025. That would surely be a healthier market IMO.
boi568 boi568 2 hours ago
I have now read the linked article, which documents the lengths of time the FDA can go with posting draft guidances that stay up on their website practically forever without any progress. The author's point is that in those cases the FDA is using the draft as its unofficial, final word -- which is a
AVXL
ducci1 ducci1 2 hours ago
ES & SPX 15--30--60 min Red Lines All Retaken---Back to Red Line Bullish !!
SPY
dstock07734 dstock07734 2 hours ago
Sounds like you are ready for UK approval.

No one is giving upfront non dilutive cash to NWBO
What a ludicrous prediction! You and your buddy really need to do homework on the company before betting against it.

Now read the following article to prime yourself fir
NWBO
ORCA ORCA 2 hours ago
Q1 REPORT IS DUE ANY DAY NOW.LET'S HOPE IT WILL BE GOOD.
RJDG
ORCA ORCA 2 hours ago
HEY DIRTY BAG.EVERYTHING FALLS ON MY LAP.
JNSH

Your Recent History

BOV
A1LN34
Alnylam Pharmaceuticals
NASDAQ
FCQDX
Bmo Private Us Special E...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads